Dosing and Tolerability of Deoxycholic Acid Versus Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas
Latest Information Update: 26 Feb 2025
At a glance
- Drugs Deoxycholic acid (Primary) ; Polidocanol
- Indications Neurofibromatosis 1
- Focus Adverse reactions
Most Recent Events
- 21 Feb 2025 Status changed from recruiting to completed.
- 10 Nov 2023 New trial record